AGP Picks
View all

IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on November 3, 2026

Astera Labs Reports Third Quarter 2026 Financial Results
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2026
Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
Tarsus Reports Third Quarter 2026 Financial Results
Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results
Varonis Announces Third Quarter 2026 Financial Results
TTEC Schedules Third Quarter 2026 Earnings Release and Webcast of Investor Conference Call
Powell Industries Announces Date and Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
BNB Standard Corporation Appoints Anthony Scaramucci to Its Board of Directors
MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
Aura Biosciences to Participate in Upcoming Investor Conference
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Xenon to Present at Upcoming Investor Conferences
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
Key Tronic Corporation Announces Results for the First Quarter of Fiscal 2027
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

IT Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.